Mark Robbins
Publications by Year
Research Areas
Cardiac Valve Diseases and Treatments, Infective Endocarditis Diagnosis and Management, Coronary Interventions and Diagnostics, Acute Myocardial Infarction Research, Blood Pressure and Hypertension Studies
Most-Cited Works
- → Incremental Prognostic Value of Elevated Baseline C-Reactive Protein Among Established Markers of Risk in Percutaneous Coronary Intervention(2001)261 cited
- → Ventilatory and Heart Rate Responses to Exercise(1999)221 cited
- → Lack of Benefit From Intravenous Platelet Glycoprotein IIb/IIIa Receptor Inhibition as Adjunctive Treatment for Percutaneous Interventions of Aortocoronary Bypass Grafts(2002)215 cited
- → Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial(2022)169 cited
- → Effect of Clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein(2001)135 cited
- → Racial Differences in the Prevalence of Severe Aortic Stenosis(2014)122 cited
- → Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control After Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial(2019)121 cited
- → Neurological Events Following Transcatheter Aortic Valve Replacement and Their Predictors(2016)99 cited
- → Impact of Renal Denervation on Patients With Obstructive Sleep Apnea and Resistant Hypertension – Insights From the SYMPLICITY HTN-3 Trial –(2016)82 cited
- → Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation(2022)45 cited